Pemafibrate ameliorates renal injury through induction of FGF21 and ketone body production in male mice by Kunihiko Takahara, Noriyuki Ouchi, Tomonobu Takikawa, Yuta Ozaki, Lixin Fang, Hiroshi Kawanishi, Minako Tatsumi, Yoshimitsu Yura, Katsuhiro Kato, Mikito Takefuji, Toyoaki Murohara, Koji Ohashi

Subjects: Get full text

Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with No... by Mona Hassan, Nooraldin Merza, Yusuf Nawras, Halah Alfatlawi, hasan al obaidi, Omar Saab, Khalid Al Zubaidi, Daniah Al-sabbagh, Sarmed mansur, Marwah Algodi, Omer Al Najafi, Rand Matbachi, Tamarah Al Hamdany, Zainab Noori, Abdallah Kobeissy

Subjects: Get full text

Pemafibrate modulates peroxisome proliferator-activated receptor alpha and prevents alcohol-associated liver disease in rats by Takashi Saito, Joseph George, Kazuaki Ozaki, Mutsumi Tsuchishima, Mikihiro Tsutsumi

Subjects: Get full text

Usefulness of pemafibrate for non-alcoholic fatty liver disease with hypertriglyceridemia by Masahiro Kikuchi, Miho Kikuchi, Masahiro Konishi

Subjects: “…pemafibrate…”
Get full text

Effect and safety of pemafibrate for patients with type 2 diabetes mellitus and hypertriglyceridemia: a retrospective analysis of clinical data by Aki Okamoto, Hirohide Yokokawa, Tomoko Nagamine, Kento Goto, Hiroshi Fukuda, Teruhiko Hisaoka, Toshio Naito

Subjects: “…Pemafibrate…”
Get full text

Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice by Tomoyo Hara, Hiroki Yamagami, Ryoko Uemoto, Akiko Sekine, Yousuke Kaneko, Kohsuke Miyataka, Taiki Hori, Mayuko Ichimura-Shimizu, Masafumi Funamoto, Takeshi Harada, Tomoyuki Yuasa, Shingen Nakamura, Itsuro Endo, Ken-ichi Matsuoka, Yutaka Kawano, Koichi Tsuneyama, Yasumasa Ikeda, Ken-ichi Aihara

Subjects: Get full text

Effect of pemafibrate in reducing intestinal long-chain fatty acid absorption and hepatic fibrosis in metabolic dysfunction-associated steatohepatitis rats by Masaya Okada, Masakazu Hanayama, Yasunori Yamamoto, Teruki Miyake, Osamu Yoshida, Eiji Takeshita, Yoshio Ikeda, Yoichi Hiasa

Subjects: Get full text

Effects of Pemafibrate on Cardio-Ankle Vascular Index (CAVI) in Patients with Type 2 Diabetes or Ischemic Heart Disease: A 24-Week Observational Study by Watanabe Y, Nonaka S, Yamaoka S, Nakamura S, Horikawa O, Yamaguchi T, Sato S, Todani S, Sugizaki Y, Ito T, Mikamo H, Takahashi M, Nagayama D, Shimizu K, Saiki A

Subjects: “…pemafibrate…”
Get full text

Treatment with pemafibrate ameliorates fatty liver index and atherogenic lipid profiles in Japanese patients with type 2 diabetes mellitus by Toru Suzuki, Toru Suzuki, Tatsuya Sato, Tatsuya Sato, Marenao Tanaka, Marenao Tanaka, Kei Nakata, Kei Nakata, Keisuke Endo, Hiroki Aida, Wataru Kawaharata, Itaru Hosaka, Araya Umetsu, Toshifumi Ogawa, Toshifumi Ogawa, Yukinori Akiyama, Masato Furuhashi

Subjects: “…pemafibrate…”
Get full text

Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose by Satoshi Shinozaki, Kouichi Miura, Toshiyuki Tahara, Hironori Yamamoto

Subjects: Get full text